Landon Goldfarb highlights the advantages conferred by Instron’s Cobot automated testing system at both the design verification and production stages of autoinjector development.
Landon Goldfarb of Instron spoke to us at Pharmapack 2026 about how the demand for life-changing drugs like GLP-1s is higher than ever, yet testing remains one of the final bottlenecks in the development process. Instron’s new Cobot testing system is designed to bridge that gap. By automating two critical stages – design verification and production – Cobot is helping partners get devices to market faster by automating high-volume testing to free up engineers for high-value parallel tasks and ensuring precision in batch release testing by removing human variability. Designed for the real world, Cobot works with most commercially available devices, and users can be up and running in just 10-15 minutes.
